Literature DB >> 25837902

Pediatric brain tumors.

Elizabeth M Wells, Roger J Packer.   

Abstract

PURPOSE OF REVIEW: Pediatric brain tumors differ from those arising in adulthood. This article discusses the presentation, location, histology, new molecular understanding, therapy, and outcome of brain tumors in children. RECENT
FINDINGS: Improved biological understanding of pediatric brain tumors is resulting in new molecular-based classification and the development of rationally designed therapeutics.
SUMMARY: The presentation of a pediatric brain tumor is dependent on the type of tumor, its location in the nervous system, and the age of the child. Diagnostic workup varies depending on the location of the tumor and the tumor's propensity to disseminate in the nervous system. Survival has improved for pediatric brain tumors, particularly medulloblastoma, as a result of improved surgical techniques and rational use of postoperative radiation and chemotherapy. For medulloblastoma, recent studies have sought to maintain or improve survival while decreasing neurologic sequelae, particularly from radiation in young children. For other childhood brain tumor types, improvements in outcome are not as clear-cut. New molecular insights will likely alter classification, risk stratification, and therapy in the near future.

Entities:  

Mesh:

Year:  2015        PMID: 25837902     DOI: 10.1212/01.CON.0000464176.96311.d1

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  15 in total

Review 1.  Chromatin remodeling defects in pediatric brain tumors.

Authors:  Alexia Klonou; Danai Spiliotakopoulou; Marios S Themistocleous; Christina Piperi; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

Review 2.  Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.

Authors:  Tammy Hennika; Oren J Becher
Journal:  J Child Neurol       Date:  2015-09-14       Impact factor: 1.987

Review 3.  Molecular Basis of Pediatric Brain Tumors.

Authors:  Alexia Klonou; Christina Piperi; Antonios N Gargalionis; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2017-07-26       Impact factor: 3.843

4.  The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis.

Authors:  Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata
Journal:  Pathol Oncol Res       Date:  2020-07-13       Impact factor: 2.874

5.  Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD).

Authors:  Maurizio Bruschi; Andrea Petretto; Armando Cama; Marco Pavanello; Martina Bartolucci; Giovanni Morana; Luca Antonio Ramenghi; Maria Luisa Garré; Gian Marco Ghiggeri; Isabella Panfoli; Giovanni Candiano
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

Review 6.  In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview.

Authors:  Zhiqin Li; Sigrid A Langhans
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

7.  Congenital tumors of the central nervous system: an institutional review of 64 cases with emphasis on tumors with unique histologic and molecular characteristics.

Authors:  Angela N Viaene; Cunfeng Pu; Arie Perry; Marilyn M Li; Minjie Luo; Mariarita Santi
Journal:  Brain Pathol       Date:  2020-08-04       Impact factor: 6.508

Review 8.  Temozolomide and oral etoposide in children with recurrent malignant brain tumors.

Authors:  Antonio Ruggiero; Anna Ariano; Silvia Triarico; Michele Antonio Capozza; Alberto Romano; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà
Journal:  Drugs Context       Date:  2020-06-02

Review 9.  Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer.

Authors:  Sévérine de Bruijn; Sébastien Anguille; Joris Verlooy; Evelien L Smits; Viggo F van Tendeloo; Maxime de Laere; Koenraad Norga; Zwi N Berneman; Eva Lion
Journal:  Cancers (Basel)       Date:  2019-09-19       Impact factor: 6.639

Review 10.  Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors.

Authors:  Rianne Haumann; Jessica Carvalho Videira; Gertjan J L Kaspers; Dannis G van Vuurden; Esther Hulleman
Journal:  CNS Drugs       Date:  2020-09-23       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.